These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28660666)

  • 1. Factors associated with the pricing of childhood vaccines in the U.S. public sector.
    Chen W; Messonnier M; Zhou F
    Health Econ; 2018 Feb; 27(2):252-265. PubMed ID: 28660666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in childhood vaccine purchase costs in the US public sector: 1996-2014.
    Chen W; Messonnier M; Zhou F
    Vaccine; 2016 Sep; 34(39):4706-4711. PubMed ID: 27522176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood vaccine purchase costs in the public sector: past trends, future expectations.
    Davis MM; Zimmerman JL; Wheeler JR; Freed GL
    Am J Public Health; 2002 Dec; 92(12):1982-7. PubMed ID: 12453820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
    Gilchrist SA; Nanni A
    Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size of clinical trials and Introductory prices of prophylactic vaccine series.
    Weinberg SH; Butchart AT; Davis MM
    Hum Vaccin Immunother; 2012 Aug; 8(8):1066-70. PubMed ID: 22854668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Reverse engineering" a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines.
    Sewell EC; Jacobson SH; Weniger BG
    Pediatr Infect Dis J; 2001 Nov; 20(11 Suppl):S45-56. PubMed ID: 11704724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the challenges to immunization practice with an economic algorithm for vaccine selection.
    Weniger BG; Chen RT; Jacobson SH; Sewell EC; Deuson R; Livengood JR; Orenstein WA
    Vaccine; 1998 Nov; 16(19):1885-97. PubMed ID: 9795397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanics and effects of European reference pricing for vaccines in Germany according to §130a Abs. 2 SGB V: an analysis using the example of influenza vaccines].
    Barth J; Hammerschmidt T; Vollmar J; Bierbaum M; Schöffski O
    Gesundheitswesen; 2014 Apr; 76(4):e7-e13. PubMed ID: 24081570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences.
    Shrestha SS; Wallace GS; Meltzer MI
    Vaccine; 2010 Aug; 28(38):6318-32. PubMed ID: 20638451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2009 Dec; 124 Suppl 5():S459-65. PubMed ID: 19948577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine shortages eliminate possibility for excess capacity in stockpiles.
    Congeni BL
    Pediatr Ann; 2004 Sep; 33(9):577-83. PubMed ID: 15462572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaps in vaccine financing for underinsured children in the United States.
    Lee GM; Santoli JM; Hannan C; Messonnier ML; Sabin JE; Rusinak D; Gay C; Lett SM; Lieu TA
    JAMA; 2007 Aug; 298(6):638-43. PubMed ID: 17684186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in provider vaccine purchase prices and payer reimbursement.
    Freed GL; Cowan AE; Gregory S; Clark SJ
    Pediatrics; 2008 Dec; 122(6):1325-31. PubMed ID: 19047253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape of vaccines in China: history, classification, supply, and price.
    Zheng Y; Rodewald L; Yang J; Qin Y; Pang M; Feng L; Yu H
    BMC Infect Dis; 2018 Oct; 18(1):502. PubMed ID: 30286735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
    Walwyn DR; Nkolele AT
    Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No Shot: US Vaccine Prices And Shortages.
    Ridley DB; Bei X; Liebman EB
    Health Aff (Millwood); 2016 Feb; 35(2):235-41. PubMed ID: 26858375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.